KEY FEATURES
Full Name | Galectin 3 |
---|---|
Synonym | LGALS3;CBP35;GALBP;GALIG;L31;LGALS2;MAC2;Lectin;Galactoside-Binding Soluble 3; |
Assay Type | Sandwich |
Reactivity | Human |
Range | 0.16-10ng/mL |
Sensitivity | 0.1ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human GAL3 in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human GAL3. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human GAL3 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human GAL3, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human GAL3. You can calculate the concentration of Human GAL3 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human GAL3 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 0.55 | 1.13 | 3.81 | 0.5 | 1.14 | 3.5 |
Standard deviation | 0.03 | 0.05 | 0.19 | 0.03 | 0.06 | 0.12 |
CV(%) | 6 | 4.47 | 4.91 | 6.46 | 4.96 | 3.53 |
RECOVERY
The recovery of Human GAL3 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 94-107 | 100 |
EDTA plasma (n=8) | 93-108 | 99 |
Cell culture media (n=8) | 90-102 | 96 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human GAL3 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with LGALS3 ELISA Kits
LGALS3BP ELISA Kit | publications with LGALS3 and LGALS3BP |
EGFR ELISA Kit | publications with LGALS3 and EGFR |
MUC1 ELISA Kit | publications with LGALS3 and MUC1 |
KRAS ELISA Kit | publications with LGALS3 and KRAS |
GEMIN4 ELISA Kit | publications with LGALS3 and GEMIN4 |
PRKCSH ELISA Kit | publications with LGALS3 and PRKCSH |
NRAS ELISA Kit | publications with LGALS3 and NRAS |
HRAS ELISA Kit | publications with LGALS3 and HRAS |
DDOST ELISA Kit | publications with LGALS3 and DDOST |
SUFU ELISA Kit | publications with LGALS3 and SUFU |
Pathways associated with LGALS3 ELISA Kit
AGE/RAGE Pathway | AGE/RAGE Pathway |
Advanced Glycosylation Endproduct Receptor Signaling Pathway | Advanced Glycosylation Endproduct Receptor Signaling Pathway |
Hedgehog Signaling Events Mediated By Gli Proteins Pathway | Hedgehog Signaling Events Mediated By Gli Proteins Pathway |
Immune System Pathway | Immune System Pathway |
Innate Immune System Pathway | Innate Immune System Pathway |
Spinal Cord Injury Pathway | Spinal Cord Injury Pathway |
Diseases associated with LGALS3 ELISA Kit
Neoplasms | publications with LGALS3 and Neoplasms |
Carcinoma | publications with LGALS3 and Carcinoma |
Adenocarcinoma | publications with LGALS3 and Adenocarcinoma |
Inflammation | publications with LGALS3 and Inflammation |
Adenoma | publications with LGALS3 and Adenoma |
Neoplasm Metastasis | publications with LGALS3 and Neoplasm Metastasis |
Disease Models, Animal | publications with LGALS3 and Disease Models, Animal |
Nervous System Diseases | publications with LGALS3 and Nervous System Diseases |
Breast Neoplasms | publications with LGALS3 and Breast Neoplasms |
Brain Diseases | publications with LGALS3 and Brain Diseases |
Organs/Tissues associated with LGALS3 ELISA Kit
Blood | publications with LGALS3 and Blood |
Thyroid | publications with LGALS3 and Thyroid |
Vascular | publications with LGALS3 and Vascular |
Brain | publications with LGALS3 and Brain |
Lung | publications with LGALS3 and Lung |
Bone | publications with LGALS3 and Bone |
Liver | publications with LGALS3 and Liver |
Heart | publications with LGALS3 and Heart |
Kidney | publications with LGALS3 and Kidney |
Skin | publications with LGALS3 and Skin |